Both in Biotechnology
Caribou Biosciences vs enGene Therapeutics
Over the past year CRBU returned −46.1% and ENGN returned −69.8%; their daily moves had a correlation of 0.16.
CRBU −46.1% ENGN −69.8%Growth of $1, one year, split-adjusted
| Metric | CRBU | ENGN |
|---|---|---|
| Price | $1.24 | $1.95 |
| Market cap | $132.9M | $130.7M |
| Today | +0.81% | −1.02% |
| 1 month | −23.5% | +6.8% |
| 6 months | −27.9% | −68.4% |
| Year to date | −22.0% | −78.4% |
| 1 year | −41.8% | −70.0% |
| Revenue growth (YoY) | −43.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −1619.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.2× | — |
| Net cash | $112.3M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 50.6% | 45.3% |
| Short % of float | 15.1% | 2.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).